` 4TO (Mainz Biomed NV) vs DAX Index Comparison - Alpha Spread

4TO
vs
D
DAX Index

Over the past 12 months, 4TO has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +13% growth.

Stocks Performance
4TO vs DAX Index

Loading
4TO
DAX Index
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
4TO vs DAX Index

Performance Gap Between 4TO and GDAXI
HIDDEN
Show

Performance By Year
4TO vs DAX Index

Loading
4TO
DAX Index
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Mainz Biomed NV vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Mainz Biomed NV
Glance View

Market Cap
175.1m EUR
Industry
Biotechnology

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The company is headquartered in Mainz, Hessen and currently employs 58 full-time employees. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.

4TO Intrinsic Value
HIDDEN
Show
Back to Top